vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Chemours Co (CC). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.3B, roughly 1.9× Chemours Co). ARGENX SE runs the higher net margin — 35.5% vs -3.5%, a 39.0% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -2.1%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $92.0M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
ARGX vs CC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.3B |
| Net Profit | $877.2M | $-47.0M |
| Gross Margin | 89.5% | 11.7% |
| Operating Margin | 28.9% | — |
| Net Margin | 35.5% | -3.5% |
| Revenue YoY | 83.2% | -2.1% |
| Net Profit YoY | 1.3% | -261.5% |
| EPS (diluted) | $13.25 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $901.9M | $1.6B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $877.2M | $-47.0M | ||
| Q3 25 | — | $46.0M | ||
| Q2 25 | $414.8M | $-380.0M | ||
| Q1 25 | — | $-5.0M | ||
| Q4 24 | $865.6M | $-13.0M | ||
| Q3 24 | — | $-32.0M | ||
| Q2 24 | $-32.5M | $60.0M | ||
| Q1 24 | — | $54.0M |
| Q4 25 | 89.5% | 11.7% | ||
| Q3 25 | — | 15.6% | ||
| Q2 25 | 89.2% | 17.2% | ||
| Q1 25 | — | 17.3% | ||
| Q4 24 | 90.2% | 19.4% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | 89.4% | 19.8% | ||
| Q1 24 | — | 20.9% |
| Q4 25 | 28.9% | — | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 19.2% | -15.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | 8.7% | -0.1% | ||
| Q3 24 | — | -2.1% | ||
| Q2 24 | -15.4% | 4.4% | ||
| Q1 24 | — | 5.1% |
| Q4 25 | 35.5% | -3.5% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | 23.4% | -23.5% | ||
| Q1 25 | — | -0.4% | ||
| Q4 24 | 64.1% | -1.0% | ||
| Q3 24 | — | -2.1% | ||
| Q2 24 | -3.6% | 3.9% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | $13.25 | $-0.32 | ||
| Q3 25 | — | $0.31 | ||
| Q2 25 | $6.32 | $-2.53 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | $13.33 | $-0.07 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | $-0.55 | $0.39 | ||
| Q1 24 | — | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $670.0M |
| Total DebtLower is stronger | — | $4.1B |
| Stockholders' EquityBook value | $7.3B | $250.0M |
| Total Assets | $8.7B | $7.4B |
| Debt / EquityLower = less leverage | — | 16.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $670.0M | ||
| Q3 25 | — | $613.0M | ||
| Q2 25 | $2.1B | $502.0M | ||
| Q1 25 | — | $464.0M | ||
| Q4 24 | $1.5B | $713.0M | ||
| Q3 24 | — | $596.0M | ||
| Q2 24 | $1.4B | $604.0M | ||
| Q1 24 | — | $746.0M |
| Q4 25 | — | $4.1B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | $11.0M | $4.0B | ||
| Q1 24 | — | $4.0B |
| Q4 25 | $7.3B | $250.0M | ||
| Q3 25 | — | $274.0M | ||
| Q2 25 | $6.1B | $228.0M | ||
| Q1 25 | — | $566.0M | ||
| Q4 24 | $5.5B | $571.0M | ||
| Q3 24 | — | $643.0M | ||
| Q2 24 | $4.3B | $714.0M | ||
| Q1 24 | — | $753.0M |
| Q4 25 | $8.7B | $7.4B | ||
| Q3 25 | — | $7.5B | ||
| Q2 25 | $7.2B | $7.5B | ||
| Q1 25 | — | $7.4B | ||
| Q4 24 | $6.2B | $7.5B | ||
| Q3 24 | — | $7.5B | ||
| Q2 24 | $4.8B | $7.2B | ||
| Q1 24 | — | $8.0B |
| Q4 25 | — | 16.40× | ||
| Q3 25 | — | 14.96× | ||
| Q2 25 | — | 17.99× | ||
| Q1 25 | — | 7.18× | ||
| Q4 24 | — | 7.11× | ||
| Q3 24 | — | 6.20× | ||
| Q2 24 | 0.00× | 5.53× | ||
| Q1 24 | — | 5.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $137.0M |
| Free Cash FlowOCF − Capex | $322.4M | $92.0M |
| FCF MarginFCF / Revenue | 13.0% | 6.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.4% |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $51.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $137.0M | ||
| Q3 25 | — | $146.0M | ||
| Q2 25 | $361.8M | $93.0M | ||
| Q1 25 | — | $-112.0M | ||
| Q4 24 | $41.9M | $138.0M | ||
| Q3 24 | — | $139.0M | ||
| Q2 24 | $-124.7M | $-620.0M | ||
| Q1 24 | — | $-290.0M |
| Q4 25 | $322.4M | $92.0M | ||
| Q3 25 | — | $105.0M | ||
| Q2 25 | $356.6M | $50.0M | ||
| Q1 25 | — | $-196.0M | ||
| Q4 24 | $40.9M | $29.0M | ||
| Q3 24 | — | $63.0M | ||
| Q2 24 | $-125.5M | $-693.0M | ||
| Q1 24 | — | $-392.0M |
| Q4 25 | 13.0% | 6.9% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | 20.1% | 3.1% | ||
| Q1 25 | — | -14.3% | ||
| Q4 24 | 3.0% | 2.1% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | -13.9% | -44.6% | ||
| Q1 24 | — | -28.8% |
| Q4 25 | 0.0% | 3.4% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | 0.3% | 2.7% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | 0.1% | 8.0% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | 0.1% | 4.7% | ||
| Q1 24 | — | 7.5% |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | 3.17× | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -10.33× | ||
| Q1 24 | — | -5.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
